4896 · K Pharma,Inc. · Financials
Market Cap
7.72B JPY
Shares
11.62M
Volume · Nov 13
17.4K
Avg daily vol (3M)
21.74K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
1B
FY2023
Net Income
-993.23M
-17.3%
FY2025
Gross Margin
91%
FY2023
Operating Margin
36.61%
FY2023
Operating Cash Flow
-918.01M
+6.7%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| JPY | — | — | 1B |
| JPY | — | — | 90M |
| JPY | — | — | 910M |
| JPY | -916.06M | -836.35M | 366.06M |
| JPY | -990.5M | -844.1M | 301.08M |
| JPY | 2.73M | 2.35M | 40.75M |
| JPY | -993.23M | -846.46M | 260.33M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.